Canada Pension Plan Investment Board Rigel Pharmaceuticals Inc Transaction History

Canada Pension Plan Investment Board

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$1.78 - $4.13 $1.19 Million - $2.76 Million	-669,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.41 - $2.05 $943,290 - $1.37 Million	669,000 New	669,000 $1.22 Million
Q4 2018 Feb 06, 2019	SELL	$2.08 - $3.36 $520,000 - $840,000	-250,000 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$2.6 - $3.59 $520,000 - $718,000	200,000 Added 400.0%	250,000 $803,000
Q2 2018 Aug 07, 2018	BUY	$2.83 - $4.11 $141,500 - $205,500	50,000 New	50,000 $142,000

355K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.77B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.